Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback